Synbio Tech (ROCO:1295) Total Equity: NT$1,330 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:1295 Synbio Tech Inc ROCO:1295
44 GF Score
Price NT$50.40
! 10 Warning Signs
View Full Analysis

What is Synbio Tech Total Equity?

Synbio Tech ROCO:1295 -0.40% 44 Total Equity is NT$1,330 Mil as of Dec. 2025. GuruFocus rates ROCO:1295 with a GF Score™ of 44/100. The stock has 10 warning signs investors should review.

Synbio Tech's total equity for the quarter that ended in Dec. 2025 was NT$1,330 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Synbio Tech Total Equity Historical Data

* Premium members only.

The historical data trend for Synbio Tech's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Synbio Tech Total Equity Chart

Synbio Tech Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial 863.17 897.68 942.97 1,079.43 1,330.16

Synbio Tech Quarterly Data
Dec20 Dec21 Dec22 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,079.43 1,019.84 1,224.32 1,270.15 1,330.16
ROCO:1295
44GF Score
Synbio Tech Inc ROCO:1295
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Synbio Tech Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Synbio Tech's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=3085.253-1755.097
=1,330

Synbio Tech's Total Equity for the quarter that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=3085.253-1755.097
=1,330

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of NT$1,330 Mil mean?
Synbio Tech (ROCO:1295) has a Total Equity of NT$1,330 Mil as of Dec. 2025. The total amount of equity as record on a company's balance sheet. View historical data for Synbio Tech and its competitors.
Is Synbio Tech's Total Equity too high?
Synbio Tech's current Total Equity is NT$1,330 Mil. Overall, Synbio Tech has a GF Score™ of 44/100, reflecting its overall financial health beyond just this single metric.
How does Synbio Tech's Total Equity compare to VRTX and REGN?
Synbio Tech's Total Equity of NT$1,330 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Biotechnology company?
A good Total Equity depends on the Biotechnology industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Synbio Tech and its competitors. Synbio Tech's current Total Equity is NT$1,330 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Synbio Tech stock overvalued right now?
Synbio Tech (ROCO:1295) has a current Total Equity of NT$1,330 Mil. The current Total Equity is NT$1,330 Mil. Synbio Tech's overall GF Score™ is 44/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Synbio Tech (ROCO:1295), the current Total Equity is NT$1,330 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Synbio Tech Business Description

Address No.82, Beiling 6th Road, Luzhu District, Kaohsiung, TWN, 821
Synbio Tech Inc focus on functional research and manufacturing of probiotics for human health and economic animals. It has two reportable segments, Taiwan and Mainland China Segment to engage in the production and R&D technologies of the Taiwan Segment, including the production and sales of concentrated fermentation liquid, lactobacillus plantarum solid drinks, and lactobacillus plantarum granules for animal husbandry. It generates majority of revenue from Taiwan segment includes production and sale of lactobacillus plantarum powder, lactobacillus plantarum fermentation derivative products, probiotics dietary supplements, probiotics products for pets and economic animals, and probiotics products. It has presence in Taiwan, China, Southeast Asia, and Others.
44GF Score

Get the complete analysis for ROCO:1295

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$50.40
Price